Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)
NCT01943461
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Avelumab 3 mg/kg
DRUG:
Avelumab 10 mg/kg
DRUG:
Avelumab 20 mg/kg
Sponsor
Merck KGaA, Darmstadt, Germany